Semaglutide Semaglutide is a GLP-1 receptor agonist prescribed in an individualized compounded injection when clinically appropriate
Some people find the effects milder, while others notice different patterns compared to single or dual-action treatments
tirzepatide semaglutide dual GIP/GLP-1 receptor agonist GLP-1 receptor agonist subcutaneous injection: 2.5 milligrams (mg), 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per dose subcutaneous injection: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg or 7.2 mg (Wegovy HD) oral tablet: 1.5 mg, 4 mg, 9 mg, or 25 mg once weekly injection: once weekly oral tablet: once daily 12.8% to 20.9% reduction from starting weight after 72 weeks 9.6% to 18.8% reduction from starting weight within 72 weeks A generic drug contains an exact copy of the active ingredient in a brand-name medication
Most restaurants accommodate dietary restrictions when asked politely
These reactions are typically transient, resolving within hours to a day or two
Easy to use Good stuff Works great Love it The whole process was very easy and very prompt